After two decades of dedication to medical research, I finally chose to invest in Cedars-Sinai Medical Center because of its focus on interdisciplinary biomedical research led by physicians and clinical researchers, as well as clinical teaching of advanced medical technologies. Currently, more than 800 research projects are underway, led by more than 230 principal investigators, in cardiovascular diseases, genetics, gene therapy, gastroenterology, neuroscience, immunology, medicine and surgery, organ transplantation, stem cells , biomedical imaging, and cancer research. A new chemical recently proved effective against an unpredictable form of drug-resistant prostate cancer, new research has found. Cedars-Sinel also develops new chemicals for the treatment of bladder, pancreatic and kidney cancers